Andrew Parkinson
- Pharmacology top 0.02%
- Pharmacogenetics and Drug Metabolism 84
- Drug-Induced Hepatotoxicity and Protection 10
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 11
- Oncology top 1%
- Drug Transport and Resistance Mechanisms 33
- Hepatology top 2%
- Liver physiology and pathology 7
-
- Hormonal and reproductive studies 15
- Hormonal Regulation and Hypertension 9
-
- Carcinogens and Genotoxicity Assessment 13
- Co-authors
- Stephen SafeAjay MadanEdward L. LeCluyseMichael P. ArlottoPeter L. BullockDavid R. DuttonAndrew J. SonderfanRobin E. Pearce
- Cited by
- PharmacologyBiochemistryOncology
- Journals
- Drug Metabolism and Disposition (24 papers)Archives of Biochemistry and Biophysics (18 papers)Biochemical Pharmacology (8 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Andrew Parkinson
118 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Pharmacology 3.3k
- Biochemistry 502
- Oncology 1.8k
- Health, Toxicology and Mutagenesis 684
- Hepatology 391
Countries citing papers authored by Andrew Parkinson
This map shows the geographic impact of Andrew Parkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Parkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Parkinson more than expected).
Fields of papers citing papers by Andrew Parkinson
This network shows the impact of papers produced by Andrew Parkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Parkinson. The network helps show where Andrew Parkinson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Parkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 9 | |
| 4 | 2022 | 5 | |
| 5 | 2020 | 3 | |
| 6 | 2018 | 18 | |
| 7 | 2015 | 50 | |
| 8 | 2013 | 28 | |
| 9 | 2009 | 32 | |
| 10 | 2006 | 15 | |
| 11 | Assessing Indirect Impacts of the EC Proposals for Video Regulation | 2006 | 12 |
| 12 | 2003 | 114 | |
| 13 | 2003 | 58 | |
| 14 | 2002 | 31 | |
| 15 | 1995 | 25 | |
| 16 | 1995 | 73 | |
| 17 | 1993 | 29 | |
| 18 | 1992 | 22 | |
| 19 | 1991 | 32 | |
| 20 | 1988 | 15 |
About Andrew Parkinson
Andrew Parkinson is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 120 papers that have together received 6.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (84 papers), Drug Transport and Resistance Mechanisms (33 papers), Hormonal and reproductive studies (15 papers), Carcinogens and Genotoxicity Assessment (13 papers), Eicosanoids and Hypertension Pharmacology (11 papers), Drug-Induced Hepatotoxicity and Protection (10 papers), Hormonal Regulation and Hypertension (9 papers) and Liver physiology and pathology (7 papers). The work is most often cited by research in Pharmacology (3.3k citations), Biochemistry (502 citations) and Oncology (1.8k citations). Andrew Parkinson has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Stephen Safe, Ajay Madan, Edward L. LeCluyse, Michael P. Arlotto, Peter L. Bullock, David R. Dutton, Andrew J. Sonderfan, Robin E. Pearce, Brian W. Ogilvie and Faraz Kazmi. Their work appears in journals such as Drug Metabolism and Disposition, Archives of Biochemistry and Biophysics, Biochemical Pharmacology, Toxicology and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.